Patent · US Expired

Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin

US7125556B1 · kind B1 · utility

0Cited by

3References

6Claims

0Family size

Inventors

Jürgen Markl · Gau-Bischofsheim, DE
Benjamin Altenhein · Wiesbaden, DE
Bernhard Lieb · Mainz, DE
Thomas Stiefel · Stuttgart, DE

Key dates

Filing date	Mar 17, 2000
Grant date	Oct 24, 2006
Priority date	—
Expiry date	Mar 17, 2020

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/855
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A nucleic acid molecule or construct alone or with a promoter suitable for expression control is contemplated that codes for a haemocyanin, a haemocyanin domain or a fragment thereof with the immunological properties of at least one domain of haemocyanin, and comprises at least one intron sequence, as well as haemocyanin fusion proteins. The construct furthermore can comprise a nucleic acid sequence that codes for an antigen. Host cells are also contemplated that contain the nucleic acid molecule or construct and a recombinant expression product thereof. The invention furthermore relates to a pharmaceutical composition that comprises the expression product and antibodies obtainable by immunization of an animal therewith, as well as the use the antibodies in screening methods for the identification of tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.